Omlonti 0.002% (0.02 mg/mL) ophthalmic solution Images
Generic Name: omidenepag isopropyl
This medication has been identified as Omlonti 0.002% (0.02 mg/mL) ophthalmic solution. It is supplied by Santen Inc.
Omlonti is used in the treatment of Glaucoma, Open Angle; Glaucoma/Intraocular Hypertension and belongs to the drug class ophthalmic glaucoma agents. Omlonti 0.002% (0.02 mg/mL) ophthalmic solution is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Omlonti
- Generic Name
- omidenepag isopropyl
- Strength
- 0.002% (0.02 mg/mL) ophthalmic solution
- Availability
- Prescription only
- Drug Class
- Ophthalmic glaucoma agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Santen Inc.
- National Drug Code (NDC)
- 65086-0002
See also:
Combigan
Combigan (brimonidine and timolol) is used to treat glaucoma or ocular hypertension. Includes ...
Vyzulta
Vyzulta is used for glaucoma, open angle, glaucoma/intraocular hypertension
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Zioptan
Zioptan (tafluprost eye drops) is used to reduce elevated intraocular pressure in patients with ...
Latanoprostene bunod ophthalmic
Latanoprostene bunod ophthalmic is used for glaucoma, open angle, glaucoma/intraocular hypertension
Tafluprost ophthalmic
Tafluprost ophthalmic is used for glaucoma, open angle, glaucoma/intraocular hypertension ...
More about Omlonti (omidenepag isopropyl ophthalmic)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: ophthalmic glaucoma agents
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.